Literature DB >> 17404300

Role of MyD88 in route-dependent susceptibility to vesicular stomatitis virus infection.

Shenghua Zhou1, Evelyn A Kurt-Jones, Katherine A Fitzgerald, Jennifer P Wang, Anna M Cerny, Melvin Chan, Robert W Finberg.   

Abstract

TLRs are important components of the innate immune response. The role of the TLR signaling pathway in host defense against a natural viral infection has been largely unexplored. We found that mice lacking MyD88, an essential adaptor protein in TLR signaling pathway, were extremely sensitive to intranasal infection with vesicular stomatitis virus, and this susceptibility was dose dependent. We demonstrated that this increased susceptibility correlates with the impaired production of IFN-alpha and defective induction and maintenance of neutralizing Ab. These studies outline the important role of the TLR signaling pathway in nasal mucosae-respiratory tracts-neuroepithelium environment in the protection against microbial pathogen infections. We believe that these results explain how the route of infection, probably by virtue of activating different cell populations, can lead to entirely different outcomes of infection based on the underlying genetics of the host.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404300     DOI: 10.4049/jimmunol.178.8.5173

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus.

Authors:  Shenghua Zhou; Anna M Cerny; An Zacharia; Katherine A Fitzgerald; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

2.  A novel Toll-like receptor that recognizes vesicular stomatitis virus.

Authors:  Zhongcheng Shi; Zhenyu Cai; Amir Sanchez; Tingting Zhang; Shu Wen; Jun Wang; Jianhua Yang; Songbin Fu; Dekai Zhang
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

3.  Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells.

Authors:  Hongmei Li; Catherine Matte-Martone; Hung Sheng Tan; Srividhya Venkatesan; Jennifer McNiff; Anthony J Demetris; Dhanpat Jain; Fadi Lakkis; David Rothstein; Warren D Shlomchik
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

Review 4.  Interplay between innate immunity and negative-strand RNA viruses: towards a rational model.

Authors:  Denis Gerlier; Douglas S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2011-09       Impact factor: 11.056

5.  MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination.

Authors:  Sang-Moo Kang; Dae-Goon Yoo; Min-Chul Kim; Jae-Min Song; Min-Kyung Park; Eunju O; Fu-Shi Quan; Shizuo Akira; Richard W Compans
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

6.  VSV oncolytic virotherapy in the B16 model depends upon intact MyD88 signaling.

Authors:  Phonphimon Wongthida; Rosa M Diaz; Feorillo Galivo; Timothy Kottke; Jill Thompson; Alan Melcher; Richard Vile
Journal:  Mol Ther       Date:  2010-10-19       Impact factor: 11.454

7.  Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection.

Authors:  Mark D Trottier; Douglas S Lyles; Carol Shoshkes Reiss
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

8.  Myd88 is required for an antibody response to retroviral infection.

Authors:  Edward P Browne; Dan R Littman
Journal:  PLoS Pathog       Date:  2009-02-13       Impact factor: 6.823

9.  Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein.

Authors:  Marlena M Westcott; Maryam Ahmed; Jason R Smedberg; Karishma R Rajani; Elizabeth M Hiltbold; Douglas S Lyles
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

10.  TRIM13 is a negative regulator of MDA5-mediated type I interferon production.

Authors:  Kavitha Narayan; Lisa Waggoner; Serena T Pham; Gabriel L Hendricks; Stephen N Waggoner; Joseph Conlon; Jennifer P Wang; Katherine A Fitzgerald; Joonsoo Kang
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.